Ceramic additive formulation and method of making

US9974310B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9974310-B2
Application numberUS-201615064777-A
CountryUS
Kind codeB2
Filing dateMar 9, 2016
Priority dateMar 9, 2016
Publication dateMay 22, 2018
Grant dateMay 22, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method of making a ceramic glaze formulation having an antimicrobial property for use with a ceramic article. The method comprises fritting an antimicrobial formulation in a flux frit, providing least one unfritted antimicrobial component, providing a silver carrier in a glass matrix, and combining the flux frit, the at least one unfritted component, and the silver carrier in the glass matrix to form the ceramic glaze formulation. The silver carrier is combined at an addition rate based on a dry weight basis of the ceramic glaze formulation. A ceramic glaze additive formulation and ceramic glazed article are also provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of making a ceramic glaze formulation having an antimicrobial property for use with a ceramic article, the method comprising: fritting an antimicrobial formulation in a flux frit, wherein the flux frit is present in the ceramic glaze formulation in an amount of 45 weight % to 55 weight %, based on a dry weight basis of the ceramic glaze formulation; providing least one unfritted antimicrobial component; providing a silver carrier in a glass matrix; combining the flux frit, the at least one unfritted component, and the silver carrier in the glass matrix to form the ceramic glaze formulation; wherein the silver carrier is combined at an addition rate of at least 1 weight % based on a dry weight basis of the ceramic glaze formulation, and wherein the unfritted component is unfritted Bi 2 O 3 present in the ceramic glaze formulation in a range of 12% to 20% by weight of the ceramic glaze formulation. 2. The method according to claim 1 , wherein the flux frit comprises an antimicrobial selected from the group consisting of zinc oxide, bismuth oxide, titanium oxide, tin oxide, silver compound, and a combination thereof. 3. The method according to claim 2 , wherein the flux frit comprises an antimicrobial selected from the group consisting of bismuth oxide, zinc oxide, and a combination thereof. 4. The method according to claim 3 , wherein the flux frit further comprises a glass former. 5. The method according to claim 3 , wherein Bi 2 O 3 is present in a range of 50% to 56% by weight of the flux frit. 6. The method according to claim 5 , wherein Bi 2 O 3 is present in a range of 52% to 54% by weight of the flux frit. 7. The method according to claim 3 , wherein ZnO is present in a range of 1% to 5% by weight of the flux frit. 8. The method according to claim 1 , wherein the unfritted component is selected from the group consisting of zinc oxide, bismuth oxide, titanium oxide, tin oxide, silver compound, and a combination thereof. 9. The method according to claim 1 , wherein the unfritted component is unfritted Bi 2 O 3 present in the ceramic glaze formulation in a range of 14% to 18% by weight of the ceramic glaze formulation. 10. The method according to claim 8 , wherein the unfritted component is unfritted ZnO present in the ceramic glaze formulation in a range of 29% to 37% by weight of the ceramic glaze formulation. 11. The method according to claim 10 , wherein the unfritted component is unfritted ZnO present in the ceramic glaze formulation in a range of 31% to 35% by weight of the ceramic glaze formulation. 12. A method of making a ceramic glaze formulation having an antimicrobial property for use with a ceramic article, the method comprising: fritting an antimicrobial formulation in a flux frit, wherein the flux frit is present in the ceramic glaze formulation in an amount of 1 weight % to 10 weight %, based on a dry weight basis of the ceramic glaze formulation; providing at least one unfritted antimicrobial component; providing a silver carrier in a glass matrix; combining the flux frit, the at least one unfritted antimicrobial component, and the silver carrier in the glass matrix to form the ceramic glaze formulation; wherein the silver carrier is added to the ceramic glaze formulation at an addition rate of at least 10 weight % based on a dry weight basis of the ceramic glaze formulation; wherein the unfritted component is selected from the group consisting of zinc oxide, bismuth oxide, titanium oxide, tin oxide, silver compound, and a combination thereof; and wherein the unfritted component is unfritted ZnO present in the ceramic glaze formulation in a range of 80% to 90% by weight of the ceramic glaze formulation. 13. The method according to claim 12 , wherein the flux frit comprises an antimicrobial selected from the group consisting of zinc oxide, bismuth oxide, titanium oxide, tin oxide, silver compound, and a combination thereof. 14. The method according to claim 13 , wherein the flux frit comprises an antimicrobial selected from the group consisting of bismuth oxide, zinc oxide, and a combination thereof. 15. The method according to claim 14 , wherein the flux frit further comprises a glass former. 16. The method according to claim 14 , wherein Bi 2 O 3 is present in a range of 50% to 56% by weight of the flux frit. 17. The method according to claim 16 , wherein Bi 2 O 3 is present in a range of 52% to 54% by weight of the flux frit. 18. The method according to claim 14 , wherein ZnO is present in a range of 1% to 5% by weight of the flux frit. 19. The method according to claim 12 , wherein the unfritted component is unfritted ZnO present in the ceramic glaze formulation in a range of 83% to 87% by weight of the ceramic glaze formulation.

Assignees

Inventors

Classifications

  • A01N59/16Primary

    Heavy metals; Compounds thereof · CPC title

  • Glazes; Cold glazes · CPC title

  • Paints containing biocides, e.g. fungicides, insecticides or pesticides (C09D5/16 takes precedence) · CPC title

  • with vitreous materials (composition of vitreous glazes and enamels C03C; ceramic pigments C09C1/0009) · CPC title

  • Glass frit mixtures having non-frit additions, e.g. opacifiers, colorants, mill-additions · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9974310B2 cover?
A method of making a ceramic glaze formulation having an antimicrobial property for use with a ceramic article. The method comprises fritting an antimicrobial formulation in a flux frit, providing least one unfritted antimicrobial component, providing a silver carrier in a glass matrix, and combining the flux frit, the at least one unfritted component, and the silver carrier in the glass matrix…
Who is the assignee on this patent?
Microban Products
What technology area does this patent fall under?
Primary CPC classification A01N59/16. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).